Alterations in KP metabolism are thought to play a dual role in MS: on the one hand, KP activation serves as a mechanism to regulate immune responses (through TRP depletion and the generation of immunomodulatory kynurenines), but on the other hand, excessive or imbalanced KP activity creates a neurotoxic environment in the CNS. This evidence concerns the gene NPPA and myeloid sarcoma.